Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lord, Joanne
and
Asante, Maxwell A.
1999.
Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis.
Health Economics,
Vol. 8,
Issue. 4,
p.
323.
Obenchain, Robert L.
1999.
RESAMPLING AND MULTIPLICITY IN COST-EFFECTIVENESS INFERENCE.
Journal of Biopharmaceutical Statistics,
Vol. 9,
Issue. 4,
p.
563.
Briggs, Andrew H.
1999.
A Bayesian approach to stochastic cost-effectiveness analysis.
Health Economics,
Vol. 8,
Issue. 3,
p.
257.
Laska, Eugene M.
Meisner, Morris
Siegel, Carole
and
Stinnett, Aaron A.
1999.
Ratio-based and net benefit-based approaches to health care resource allocation: proofs of optimality and equivalence.
Health Economics,
Vol. 8,
Issue. 2,
p.
171.
Gardiner, Joseph C.
Bradley, Cathy J.
and
Huebner, Marianne
2000.
Bioenvironmental and Public Health Statistics.
Vol. 18,
Issue. ,
p.
841.
O’Hagan, Anthony
Stevens, John W.
and
Montmartin, Jacques
2000.
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio.
PharmacoEconomics,
Vol. 17,
Issue. 4,
p.
339.
L�thgren, Mickael
and
Zethraeus, Niklas
2000.
Definition, interpretation and calculation of cost-effectiveness acceptability curves.
Health Economics,
Vol. 9,
Issue. 7,
p.
623.
Gardiner, Joseph C.
Huebner, Marianne
Jetton, James
and
Bradley, Cathy J.
2000.
Power and sample assessments for tests of hypotheses on cost-effectiveness ratios.
Health Economics,
Vol. 9,
Issue. 3,
p.
227.
O'Brien, Bernie J.
and
Sculpher, Mark J.
2000.
Building Uncertainty Into Cost-Effectiveness Rankings.
Medical Care,
Vol. 38,
Issue. 5,
p.
460.
Laska, Eugene M.
Meisner, Morris
Siegel, Carole
and
Wanderling, Joseph
2001.
Statistical cost‐effectiveness analysis of two treatments based on net health benefits.
Statistics in Medicine,
Vol. 20,
Issue. 8,
p.
1279.
O'Hagan, Anthony
Stevens, John W.
and
Montmartin, Jacques
2001.
Bayesian cost‐effectiveness analysis from clinical trial data.
Statistics in Medicine,
Vol. 20,
Issue. 5,
p.
733.
Briggs, Andrew
and
Tambour, Magnus
2001.
The Design and Analysis of Stochastic Cost-Effectiveness Studies for the Evaluation of Health Care Interventions.
Drug Information Journal,
Vol. 35,
Issue. 4,
p.
1455.
Willan, Andrew R.
2001.
Analysis, Sample Size, and Power for Estimating Incremental Net Health Benefit from Clinical Trial Data.
Controlled Clinical Trials,
Vol. 22,
Issue. 3,
p.
228.
Willan, Andrew R.
O'Brien, Bernie J.
and
Leyva, Rina A.
2001.
Cost‐effectiveness analysis when the WTA is greater than the WTP.
Statistics in Medicine,
Vol. 20,
Issue. 21,
p.
3251.
Willan, Andrew R
2001.
On the probability of cost-effectiveness using data from randomized clinical trials.
BMC Medical Research Methodology,
Vol. 1,
Issue. 1,
Zivin, Joshua Graff
2001.
Cost‐effectiveness analysis with risk aversion.
Health Economics,
Vol. 10,
Issue. 6,
p.
499.
Willan, Andrew R.
and
Lin, D. Y.
2001.
Incremental net benefit in randomized clinical trials.
Statistics in Medicine,
Vol. 20,
Issue. 11,
p.
1563.
Meltzer, David
2001.
Addressing uncertainty in medical cost–effectiveness analysis.
Journal of Health Economics,
Vol. 20,
Issue. 1,
p.
109.
Johnson-Masotti, Ana P.
Laud, Purushottam W.
Hoffmann, Raymond G.
Hayat, Matthew J.
and
Pinkerton, Steven D.
2001.
Probabilistic Cost-Effectiveness Analysis of HIV Prevention.
Evaluation Review,
Vol. 25,
Issue. 4,
p.
474.
O'Hagan, Anthony
and
Stevens, John W.
2001.
A framework for cost‐effectiveness analysis from clinical trial data.
Health Economics,
Vol. 10,
Issue. 4,
p.
303.